Viewing pictures of social interaction can facilitate approach behaviors. We conducted two studies to investigate if social interaction cues, empathy, and/or social touch modulate facial electromyographic (EMG) reactivity (as evidenced by the zygomaticus major and corrugator supercilii muscles) and mood states. We presented bonding pictures (depicting social interaction) and control pictures (without social interaction) while continuously recording zygomatic and corrugator EMG activities. In both studies, picture blocks were paired by valence and arousal. All participants were college students. In study 1, participants (n = 80, 47 women) read relevant priming texts immediately before viewing each block of 14 pictures. In study 2, participants did not read (n = 82, 63 women) priming texts before each block of 28 pictures. In study 1 and study 2, participants also completed mood states questionnaires to assess sociability and altruistic behavior. Empathy and social touch frequency were also assessed by self-reported questionnaires. In both studies, bonding pictures increased the zygomatic activity and the self-reported sociability feeling compared to control pictures. Only in study 2, bonding pictures decreased median corrugator activity compared to control pictures. We concluded that social interaction cues were efficient to increase sociability and prompt a sustained smile expression regardless of priming texts.

This study aimed to investigate the potential of an oral formulation (QV formulation) containing Quercetin and a Dipeptidyl Peptidase-4 Inhibitor (DPP-4 inhibitor), Vildagliptin, in improving metabolic homeostasis in type 1 diabetes model. Female albino Fischer rats were divided into four groups: untreated control animals (C), untreated diabetic animals (D), diabetic animals treated with QV formulation (DQV), and diabetic animals treated with insulin (DI). Diabetes was induced by injection of alloxan (135 mg kg body mass)−1 and confirmed by glycemic test. After the 30-day treatment period, biochemical parameters were analyzed in the pancreas, liver, and serum. Histopathological changes in pancreatic tissue were examined by Hematoxyline & Eosin staining and the insulin content in the islet measured by immunohistochemistry with anti-insulin antibody. The glycogen content in the hepatocytes was quantified by Periodic Schiff Acid staining. The QV formulation reduced the glycemia, preserved the pancreatic architecture, increased insulin levels, furthermore ameliorated lipid profile and to promote higher survival rate of animals. Together, our data suggest that the QV formulation treatment was able to normalize metabolic homeostasis in type 1 diabetic rats.